A coating strategy to enhance endothelial restoration by utilizing 'pro-healing' substances not eluted by the stent, but which attract endothelial cells, may reduce the thrombogenicity of the device.

The coronary stent market in the Asia-Pacific (APAC) region is witnessing sustained growth, driven by rising coronary artery ...

The first drug-eluting stents (DESs) were approved by the FDA ... bare-metal stents (BMSs), in patients undergoing percutaneous coronary intervention. Use of these stents rapidly became widespread ...

The use of drug-eluting stents (DES) has become widespread as a result of their superior revascularization rates compared with those of bare-metal stents (BMS). 1 DES are increasingly being used ...

Blagosklonny goes on to write that even though rapamycin may reverse some manifestations of aging, it is more effective at slowing down aging than reversing it. Thus, rapamycin could be most effective ...

China plays a central role in this regional trend, as the country has seen a substantial rise in percutaneous coronary ...

Coronary artery bypass grafting is a more invasive procedure where surgeons use blood vessels from another part of the body to create a new route for blood to flow around blocked arteries. It is ...

The study, dubbed TECTONIC, is slated to enroll up to 335 people with coronary artery disease ... which includes drug-eluting stents as well as optical coherence tomography-equipped imaging ...

After domestic medical device manufacturers raised serious concerns over Gujarat’s new coronary stent pricing model, which ...

The optimization of the major stent components such as the stent platform, the polymer and the drug, have led to a very low incidence of stent thrombosis with second-generation polymer stents as ...